Roche Holding AG Ordinary Shares new
ROP: XSWX (CHE)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| N%y | LOCK|nRz | LOCK|qD?<@G%H |
Roche Earnings: Shares Undervalued as Firm Enters Year Heavy With Pipeline Catalysts
Roche reported 3% top-line growth for the full year, with constant currency growth of 7% on the top line, and 14% for operating profit. Management guided to mid-single-digit sales growth and high-single-digit core earnings per share growth for 2025.
